{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:56:57Z","timestamp":1790312217210,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parkinson's Disease Queensland"},{"DOI":"10.13039\/501100014673","name":"Menzies Health Institute Queensland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014673","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12640-017-9825-7","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T06:45:00Z","timestamp":1508827500000},"page":"229-238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Dexamethasone Inhibits Copper-Induced Alpha-Synuclein Aggregation by a Metallothionein-Dependent Mechanism"],"prefix":"10.1007","volume":"33","author":[{"given":"Fleur A.","family":"McLeary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre N.","family":"Rcom-H\u2019cheo-Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Goulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien K.","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Mellick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean L.","family":"Pountney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"9825_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.brainres.2009.11.085","volume":"1319","author":"N Arnal","year":"2010","unstructured":"Arnal N, de Alaniz MJ (2010) Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives. Brain Res 1319:118\u2013130","journal-title":"Brain Res"},{"key":"9825_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cbpa.2008.02.019","volume":"12","author":"KJ Barnham","year":"2008","unstructured":"Barnham KJ, Bush AI (2008) Metals in Alzheimers and Parkinsons diseases. Curr Opin Chem Biol 12:222\u2013228","journal-title":"Curr Opin Chem Biol"},{"key":"9825_CR3","first-page":"17","volume":"2","author":"DM Branco","year":"2010","unstructured":"Branco DM et al (2010) Cross-talk between mitochondria and proteasome in Parkinson\u2019s disease pathogenesis. Front Aging Neurosci 2:17","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"9825_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1021\/tx900338d","volume":"23","author":"GJ Brewer","year":"2010","unstructured":"Brewer GJ (2010) Risks of copper and iron toxicity during aging in humans. Chem Res Toxicol 23(2):319\u2013326","journal-title":"Chem Res Toxicol"},{"key":"9825_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","volume":"1822","author":"L Breydo","year":"2012","unstructured":"Breydo L, Wu JW, Uversky VN (2012) Alpha-synuclein misfolding and Parkinson\u2019s disease. Biochim Biophys Acta 1822:261\u2013285","journal-title":"Biochim Biophys Acta"},{"key":"9825_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1006\/bbrc.1999.1073","volume":"261","author":"J Camarakis","year":"1999","unstructured":"Camarakis J, Voskoboinik I, Mercer JF (1999) Molecular mechanisms of copper homeostasis. Biochem Biophys Res Commun 261:225\u2013232","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"9825_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nn1443","volume":"8","author":"LI Chen","year":"2005","unstructured":"Chen LI, Feany MB (2005) \u03b1-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 8(5):657\u2013663","journal-title":"Nat Neurosci"},{"issue":"22","key":"9825_CR8","doi-asserted-by":"publisher","first-page":"15349","DOI":"10.1074\/jbc.M708446200","volume":"283","author":"RS Chung","year":"2008","unstructured":"Chung RS et al (2008) Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J Biol Chem 283(22):15349\u201315358","journal-title":"J Biol Chem"},{"issue":"8","key":"9825_CR9","doi-asserted-by":"publisher","first-page":"e12030","DOI":"10.1371\/journal.pone.0012030","volume":"5","author":"RS Chung","year":"2010","unstructured":"Chung RS et al (2010) The native copper- and zinc-binding protein metallothionein blocks copper-mediated abeta aggregation and toxicity in rat cortical neurons. PLoS One 5(8):e12030","journal-title":"PLoS One"},{"issue":"5","key":"9825_CR10","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades N et al (2012) Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein. Cell 149(5):1048\u20131059","journal-title":"Cell"},{"issue":"4","key":"9825_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.neurobiolaging.2013.09.034","volume":"35","author":"KM Davies","year":"2014","unstructured":"Davies KM et al (2014) Copper pathology in vulnerable brain regions in Parkinson\u2019s disease. Neurobiol Aging 35(4):858\u2013866","journal-title":"Neurobiol Aging"},{"issue":"8","key":"9825_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1042\/CS20150153","volume":"130","author":"KM Davies","year":"2016","unstructured":"Davies KM, Mercer JF, Chen N, Double KL (2016) Copper dyshomoeostasis in Parkinson\u2019s disease: implications for pathogenesis and indications for novel therapeutics. Clin Sci (Lond) 130(8):565\u2013574","journal-title":"Clin Sci (Lond)"},{"issue":"16","key":"9825_CR13","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/cbic.201500425","volume":"16","author":"R De Ricco","year":"2015","unstructured":"De Ricco R, Valensin D, Dell'Acqua S, Casella L, Hureau C, Faller P (2015) Copper(I\/II), \u03b1\/\u03b2-synuclein and amyloid-\u03b2: menage \u00e0 trois. Chembiochem 16(16):2319\u20132328","journal-title":"Chembiochem"},{"issue":"11","key":"9825_CR14","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/nar\/20.11.2755","volume":"20","author":"J Filmus","year":"1992","unstructured":"Filmus J, Remani J, Klein MH (1992) Synergistic induction of promoters containing metal- and glucocorticoid-responsive elements. Nucleic Acids Res 20(11):2755\u20132760","journal-title":"Nucleic Acids Res"},{"key":"9825_CR15","doi-asserted-by":"crossref","unstructured":"Finkelstein DI, Hare DJ, Billings JL, Sedjahtera A, Nurjono M, Arthofer E, George S, Culvenor JG, Bush AI, Adlard PA (2016) Clioquinol improves cognitive, motor function, and microanatomy of the alpha-synuclein hA53T transgenic mice. ACS Chem Neurosci 7(1):119\u2013129","DOI":"10.1021\/acschemneuro.5b00253"},{"key":"9825_CR16","doi-asserted-by":"crossref","unstructured":"Fitzgerald M, Nairn P, Bartlett CA, Chung RS, West AK, Beazley LD (2007) Metallothionein-IIA promotes neurite growth via the megalin receptor. Exp Brain Res 183(2):171\u2013180","DOI":"10.1007\/s00221-007-1032-y"},{"key":"9825_CR17","unstructured":"Gedamu L, Sadhu C (1989) Metal-specific posttranscriptional control of human metallothionein genes. Mol Cell Biol 9(12):5738\u20135741"},{"key":"9825_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33\u201339","journal-title":"Arch Neurol"},{"issue":"4","key":"9825_CR19","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/1389201011314040004","volume":"14","author":"I Hozumi","year":"2013","unstructured":"Hozumi I (2013) Roles and therapeutic potential of metallothioneins neurodegenerative diseases. Curr Pharm Biotechnol 14(4):408\u2013413","journal-title":"Curr Pharm Biotechnol"},{"issue":"1\u20132","key":"9825_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jns.2011.01.003","volume":"303","author":"I Hozumi","year":"2011","unstructured":"Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T (2011) Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci 303(1\u20132):95\u201399","journal-title":"J Neurol Sci"},{"issue":"1","key":"9825_CR21","first-page":"1","volume":"3","author":"P Jenner","year":"2013","unstructured":"Jenner P et al (2013) Parkinson\u2019s disease\u2014the debate on the clinical phenomenology, aetiology, pathology and pathogenesis. J Park Dis 3(1):1\u201311","journal-title":"J Park Dis"},{"key":"9825_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1289\/ehp.8454111","volume":"54","author":"M Karin","year":"1984","unstructured":"Karin M, Richards RI (1984) The human metallothionein gene family: structure and expression. Environ Health Perspect 54:111\u2013115","journal-title":"Environ Health Perspect"},{"issue":"3","key":"9825_CR23","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/0006-291X(80)90808-6","volume":"92","author":"M Karin","year":"1980","unstructured":"Karin M, Herschman HR, Weinstein D (1980) Primary induction of metallothionein by dexamethasone in cultured rat hepatocytes. Biochem Biophys Res Commun 92(3):1052\u20131059","journal-title":"Biochem Biophys Res Commun"},{"key":"9825_CR24","doi-asserted-by":"crossref","unstructured":"Kurkowska-Jastrzebska I, Litwin T, Joniec I, Ciesielska A, Przyby\u0142kowski A, Cz\u0142onkowski A, Cz\u0142onkowska A (2004). Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson\u2019s disease. Int Immunopharmacol 4(10):1307\u20131318","DOI":"10.1016\/j.intimp.2004.05.006"},{"key":"9825_CR25","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesv T (2009) Parkinson\u2019s disease. Lancet 373:2055\u20132066","journal-title":"Lancet"},{"issue":"3","key":"9825_CR26","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1152\/physrev.00004.2006","volume":"87","author":"S Lutsenko","year":"2007","unstructured":"Lutsenko S et al (2007) Function and regulation of human copper-transporting ATPases. Physiol Rev 87(3):1011\u20131046","journal-title":"Physiol Rev"},{"key":"9825_CR27","doi-asserted-by":"crossref","unstructured":"Magaki S, Raghavan R, Mueller C, Oberg KC, Vinters HV, Kirsch WM (2007) Iron, copper, and iron regulatory protein 2 in Alzheimer\u2019s disease and related dementias. Neurosci Lett 418(1):72\u201376","DOI":"10.1016\/j.neulet.2007.02.077"},{"key":"9825_CR28","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1038\/cddis.2012.94","volume":"3","author":"O Marques","year":"2012","unstructured":"Marques O, Outeiro TF (2012) Alpha-synuclein: from secretion to dysfunction and death. Cell Death Dis 3:e350","journal-title":"Cell Death Dis"},{"issue":"11","key":"9825_CR29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.freeradbiomed.2011.02.003","volume":"50","author":"G Meloni","year":"2011","unstructured":"Meloni G, Va\u0161\u00e1k M (2011) Redox activity of \u03b1-synuclein-cu is silenced by Zn7-metallothionein-3. Free Radic Biol Med 50(11):1471\u20131479","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"9825_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1248\/bpb.29.55","volume":"29","author":"H Nakano","year":"2006","unstructured":"Nakano H et al (2006) Human metallothionein gene expression is upregulated by beta-thujaplicin: possible involvement of protein kinase C and reactive oxygen species. Biol Pharm Bull 29(1):55\u201359","journal-title":"Biol Pharm Bull"},{"key":"9825_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1248\/jhs.50.332","volume":"50","author":"F Otsuka","year":"2004","unstructured":"Otsuka F (2004) Transcriptional regulation of the metallothionein genes. J Health Sci 50:332\u2013335","journal-title":"J Health Sci"},{"key":"9825_CR32","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1042\/bj3400821","volume":"340","author":"SR Paik","year":"1999","unstructured":"Paik SR et al (1999) Copper(II)-induced self oligomerization of alpha-synuclein. Biochem J 340:821\u2013828","journal-title":"Biochem J"},{"key":"9825_CR33","doi-asserted-by":"crossref","unstructured":"Pall HS, Blake DR, Gutteridge JM, Williams AC, Lunec J, Hall M, Taylor A (1987) Raised cerebrospinal-fluid copper concentration in Parkinson\u2019s disease. Lancet 330(8553):238\u2013241","DOI":"10.1016\/S0140-6736(87)90827-0"},{"key":"9825_CR34","first-page":"431","volume-title":"Handbook of metal\u2013ligand interactions in biological fluids: bioinorganic chemistry, vol. 1","author":"DL Pountney","year":"1995","unstructured":"Pountney DL, Kaegi JHR, Vasak M (1995) Metallothioneins. In: Berthon G (ed) Handbook of metal\u2013ligand interactions in biological fluids: bioinorganic chemistry, vol. 1. Marcel Dekker Inc., New York, p 431"},{"issue":"1","key":"9825_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12640-009-9146-6","volume":"19","author":"DL Pountney","year":"2011","unstructured":"Pountney DL et al (2011) Association of metallothionein-III with oligodendroglial cytoplasmic inclusions in multiple system atrophy. Neurotox Res 19(1):115\u2013122","journal-title":"Neurotox Res"},{"issue":"5","key":"9825_CR36","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/acel.12112","volume":"12","author":"Y Pushkar","year":"2013","unstructured":"Pushkar Y et al (2013) Aging results in copper accumulations in glial fibrillary acidic protein-positive cells in the subventricular zone. Aging Cell 12(5):823\u2013832","journal-title":"Aging Cell"},{"key":"9825_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/srep00011","volume":"1","author":"F Rose","year":"2011","unstructured":"Rose F, Hodak M, Bernholc J (2011) Mechanism of copper(II)-induced misfolding of Parkinson\u2019s disease protein. Sci Rep 1:11","journal-title":"Sci Rep"},{"issue":"11","key":"9825_CR38","doi-asserted-by":"publisher","first-page":"10710","DOI":"10.1074\/jbc.M308434200","volume":"279","author":"H Sawada","year":"2004","unstructured":"Sawada H, Kohno R, Kihara T, Izumi Y, Sakka N, Ibi M, Nakanishi M, Nakamizo T, Yamakawa K, Shibasaki H, Yamamoto N (2004) Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes \u03b1-synuclein inclusions. J Biol Chem 279(11):10710\u201310719","journal-title":"J Biol Chem"},{"key":"9825_CR39","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1096\/fj.03-1112rev","volume":"18","author":"A Sidhu","year":"2004","unstructured":"Sidhu A, Wersinger C, Vernier P (2004) Does a-synuclien modulate dopamine synaptic content and tone at the synapse? FASEB J 18:637\u2013647","journal-title":"FASEB J"},{"issue":"4","key":"9825_CR40","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3233\/JAD-131247","volume":"38","author":"R Squitti","year":"2014","unstructured":"Squitti R et al (2014) Meta-analysis of serum non-ceruloplasmin copper in Alzheimer\u2019s disease. J Alzheimers Dis: JAD 38(4):809\u2013822","journal-title":"J Alzheimers Dis: JAD"},{"issue":"2","key":"9825_CR41","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2(2):a009399","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"9825_CR42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13311-015-0346-x","volume":"12","author":"E Tokuda","year":"2015","unstructured":"Tokuda E, Watanabe S, Okawa E, Ono S (2015) Regulation of intracellular copper by induction of endogenous metallothioneins improves the disease course in a mouse model of amyotrophic lateral sclerosis. Neurotherapeutics 12(2):461\u2013476","journal-title":"Neurotherapeutics"},{"key":"9825_CR43","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nature08300","volume":"460","author":"KJ Waldron","year":"2009","unstructured":"Waldron KJ et al (2009) Metallothioneins and metal sensing. Nature 460:823\u2013830","journal-title":"Nature"},{"issue":"6","key":"9825_CR44","doi-asserted-by":"publisher","first-page":"e38545","DOI":"10.1371\/journal.pone.0038545","volume":"7","author":"OW Wan","year":"2012","unstructured":"Wan OW, Chung KKK (2012) The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson\u2019s disease. PLoS One 7(6):e38545","journal-title":"PLoS One"},{"key":"9825_CR45","doi-asserted-by":"crossref","unstructured":"West AK, Stallings R, Hildebrand CE, Chiu R, Karin M, Richards RI (1990) Human metallothionein genes: structure of the functional locus at 16q13. Genomics 8(3):513\u2013518","DOI":"10.1016\/0888-7543(90)90038-V"},{"issue":"3","key":"9825_CR46","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuro.2007.12.006","volume":"29","author":"AK West","year":"2008","unstructured":"West AK et al (2008) Metallothionein in the central nervous system: roles in protection, regeneration and cognition. Neurotoxicology 29(3):489\u2013503","journal-title":"Neurotoxicology"},{"key":"9825_CR47","unstructured":"Wordham L (2013) Alpha-synuclein and Parkinson\u2019s disease. Available at: \n                    https:\/\/www.michaeljfox.org"},{"issue":"49","key":"9825_CR48","doi-asserted-by":"publisher","first-page":"11165","DOI":"10.1523\/JNEUROSCI.2559-04.2004","volume":"24","author":"L Yavich","year":"2004","unstructured":"Yavich L et al (2004) Role of a-synuclein in presynaptic dopamine recruitment. J Neurosci 24(49):11165\u201311170","journal-title":"J Neurosci"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-017-9825-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9825-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9825-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:21:34Z","timestamp":1589736094000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-017-9825-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["9825"],"URL":"https:\/\/doi.org\/10.1007\/s12640-017-9825-7","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]},"assertion":[{"value":"3 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}